AstraZeneca Plc, among the drugmakers directing the struggle against Covid-19, highlighted in which its expansion will come out following the pandemic having a 39 billion agreement to get rare-disease expert Alexion Pharmaceuticals Inc.. The suggested cash-and-stock acquisition will include remedies for rare blood and gynecological ailments to the portfolio of Cambridge, U.K.-based AstraZeneca, that had […]